BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 22792330)

  • 21. S100A2: A potential biomarker to differentiate malignant from tuberculous pleural effusion.
    Wang T; Wang N; Zhang L; Liu Y; Thakur A
    Indian J Cancer; 2021; 58(2):241-247. PubMed ID: 33402562
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pleural SC5b-9 in differential diagnosis of tuberculous, malignant, and other effusions.
    Hara N; Abe M; Inuzuka S; Kawarada Y; Shigematsu N
    Chest; 1992 Oct; 102(4):1060-4. PubMed ID: 1395743
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Determination and significance of interleukin-16 in tuberculous and malignant pleural effusion].
    Huang ZX; Shi HZ; Kang LF; Qin XJ; Mo WN; Chen YQ
    Zhonghua Nei Ke Za Zhi; 2006 Mar; 45(3):199-201. PubMed ID: 16624150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Triggering receptor expressed on myeloid cells-1 in pleural effusions: a marker of inflammatory disease.
    Liu CL; Hsieh WY; Wu CL; Kuo HT; Lu YT
    Respir Med; 2007 May; 101(5):903-9. PubMed ID: 17097866
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determination of Interleukin 27-Producing CD4(+) and CD8(+) T Cells for The Differentiation Between Tuberculous and Malignant Pleural Effusions.
    Liu YL; Wu YB; Zhai K; Wang XJ; Shi HZ
    Sci Rep; 2016 Jan; 6():19424. PubMed ID: 26783266
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differentiating tuberculous from malignant pleural effusions: a scoring model.
    Porcel JM; Vives M
    Med Sci Monit; 2003 May; 9(5):CR175-80. PubMed ID: 12761453
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predicting malignant and tuberculous pleural effusions through demographics and pleural fluid analysis of patients.
    Valdés L; San-José E; Ferreiro L; Golpe A; González-Barcala FJ; Toubes ME; Rodríguez-Álvarez MX; Álvarez-Dobaño JM; Rodríguez-Núñez N; Rábade C; Gude F
    Clin Respir J; 2015 Apr; 9(2):203-13. PubMed ID: 25849297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Useful tests on the pleural fluid in the management of patients with pleural effusions.
    Light RW
    Curr Opin Pulm Med; 1999 Jul; 5(4):245-9. PubMed ID: 10407695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tuberculous effusion: ADA activity correlates with CD4+ cell numbers in the fluid and the pleura.
    Gaga M; Papamichalis G; Bakakos P; Latsi P; Samara I; Koulouris NG; Alchanatis N; Orphanidou D
    Respiration; 2005; 72(2):160-5. PubMed ID: 15824526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The comparison of pleural fluid TNF-alpha and IL-10 levels with ADA in tuberculous pleural effusion.
    Ciledag A; Kaya A; Erol S; Sen E; Celik G; Cesur S; Fidan Y; Kinikli S
    Curr Med Chem; 2010; 17(19):2096-100. PubMed ID: 20423308
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Vascular endothelial growth factor in benign and malignant pleural effusions].
    Kaya A; Poyraz B; Celik G; Ciledag A; Gulbay BE; Savas H; Savas I
    Arch Bronconeumol; 2005 Jul; 41(7):376-9. PubMed ID: 16029730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between elevated pleural interleukin-33 levels and tuberculous pleurisy.
    Lee KS; Kim HR; Kwak S; Choi KH; Cho JH; Lee YJ; Lee MK; Lee JH; Park SD; Park DS
    Ann Lab Med; 2013 Jan; 33(1):45-51. PubMed ID: 23301222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Diagnostic value of interleukin-27 in tuberculous pleural effusion].
    Sun M; Yan D; Jiang S; Gu X; Ma W
    Zhonghua Yi Xue Za Zhi; 2014 Sep; 94(34):2641-4. PubMed ID: 25511588
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential diagnostic value of serum/pleural fluid IL-31 levels for tuberculous pleural effusion.
    Gao Y; Ou Q; Wu J; Zhang B; Shen L; Chen S; Weng X; Zhang Y; Zhang W; Shao L
    Sci Rep; 2016 Feb; 6():20607. PubMed ID: 26864868
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of pleural fluid human epididymis 4 (HE4) as a marker of malignant pleural effusion.
    Elsammak MY; Attia A; Hassan HA; Zaytoun TM; Shorman M; Suleman M
    Tumour Biol; 2012 Oct; 33(5):1701-7. PubMed ID: 22684816
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolomic analysis based on 1H-nuclear magnetic resonance spectroscopy metabolic profiles in tuberculous, malignant and transudative pleural effusion.
    Wang C; Peng J; Kuang Y; Zhang J; Dai L
    Mol Med Rep; 2017 Aug; 16(2):1147-1156. PubMed ID: 28627685
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The diagnostic role of glycosaminoglycans in pleural effusions: a pilot study.
    Vavetsi R; Bonovas S; Polizou P; Papanastasopoulou C; Dougekou G; Sitaras NM
    BMC Pulm Med; 2009 Feb; 9():9. PubMed ID: 19226451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical investigation of the diagnostic value of interferon-gamma, interleukin-12 and adenosine deaminase isoenzyme in tuberculous pleurisy].
    Tian RX; Gao ZC
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Jul; 27(7):435-8. PubMed ID: 15312552
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The value of exfoliative cell cytology in the diagnosis of exudative pleural effusions.
    Tetikkurt C; Yılmaz N; Tetikkurt S; Gundogdu Ş; Disci R
    Monaldi Arch Chest Dis; 2018 Sep; 88(3):944. PubMed ID: 30203633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of age on the diagnostic accuracy of soluble biomarkers for tuberculous pleural effusion: a post hoc analysis.
    Jiang CG; Wang W; Zhou Q; Wu XZ; Wang XJ; Wang Z; Zhai K; Shi HZ
    BMC Pulm Med; 2020 Jun; 20(1):178. PubMed ID: 32571326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.